Business
Currency:CNY
2023/FY
Stock NameRevenueRatio
Pharmaceutical product sales5.73B92.30%
Authorization fee income447.43M7.21%
Income from R & D service charges30.33M0.49%
Product
No Data
Region
Currency:CNY
2023/FY
Stock NameRevenueRatio
China5.75B92.71%
United States of America.442.6M7.13%
Other10.12M0.16%